# Xian-Hua-Cha for Relieving Hyperlipidemia With Obesity

Study · id `cardio:ct-nct05632068` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05632068](<https://clinicaltrials.gov/study/NCT05632068>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05632068

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT05632068. Randomized; no masking; primary purpose treatment. Start 2022-12-13 (actual); primary completion 2024-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT05632068, source copy `cardio:ctgov-nct05632068-2024-10-08`, retrieved 2026-10-31)
- Started: 2022-12-13 (actual) (ClinicalTrials.gov record NCT05632068, source copy `cardio:ctgov-nct05632068-2024-10-08`, retrieved 2026-10-31)
- Primary completion: 2024-12-31 (anticipated) (ClinicalTrials.gov record NCT05632068, source copy `cardio:ctgov-nct05632068-2024-10-08`, retrieved 2026-10-31)
- Completion: 2025-06-30 (anticipated) (ClinicalTrials.gov record NCT05632068, source copy `cardio:ctgov-nct05632068-2024-10-08`, retrieved 2026-10-31)
- Countries: Taiwan (ClinicalTrials.gov record NCT05632068, source copy `cardio:ctgov-nct05632068-2024-10-08`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05632068-2024-10-08`, retrieved 2026-10-31)

## The registry's words

- Brief title: Xian-Hua-Cha for Relieving Hyperlipidemia With Obesity
- Condition: Hyperlipidemias
- Condition: Obesity
- Condition: Body Fat Disorder
- Intervention (Drug): Xian-Hua-Cha
- Lead sponsor: Chang Gung Memorial Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry lists this organization as the lead sponsor: Chang Gung Memorial Hospital (`cardio:org-chang-gung-memorial-hospital`)

## Provenance

Content hash: 8fe4e7cb76f0a4bc993b7f6ddeecac5c784347bb97ac471faf2c8af3a6493248
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
